Hardy Diagnostics hires research and development manager

Will accelerate entry into new molecular markets

Christopher Crowe has joined Hardy Diagnostics, the Californian developer of products for the identification of products for the culture and identification of bacteria and fungi, as research and development manager.

Crowe will lead the company’s r&d and team in developing products for the diagnostic laboratory. He was recently involved in launching a product line for the molecular biology market known as CulGenex.

In addition, Crowe is expanding Hardy Diagnostics’ line of chromogenic media, which detect bacteria quickly and easily due to a colour change produced by the organisms after coming into contact with the culture media.

Jay Hardy, president of Hardy Diagnostics, said Crowe’s knowledge of molecular biology techniques would accelerate the firm’s entry into new markets.

You may also like

Cleaning

Hardy Diagnostics launches new ready-to-use dehydrated culture plate

US-based microbiological testing firm Hardy has launched a product that provides total aerobic plate counts in 24 hours
Regulatory

AloeSafe hand sanitiser is free from toxic chemicals

Leaves hands soft and silky
You need to be a subscriber to read this article.
Click here to find out more.
HVAC

Air cleanliness and particle deposition rate: The data on if a polymeric mat makes a difference

Koos Agricola from Brookhuis Applied Technologies, Olof Teulings from NTS and Carlos Mourelle from Dycem look back at their joint investigation to determine the true impact of a polymeric mat at the entrance of a cleanroom
Hi Tech Manufacturing

Miele launches entry-level ExploreLine glasswasher for small laboratories

Compact solution automates cleaning while reducing time, water and breakages
Design & Build

BioClad awarded patent for antimicrobial modular wall plumbing unit for hospitals and cleanrooms

UK-based hygienic wall cladding expert BioClad has been awarded a patent for its  “Integrated Plumbing System Apparatus and Method of Manufacture”
Containment

BLOCK to create a real-time monitoring prototype for gene therapy production in isolators

Containment product expert BLOCK Technology has been working since January 2025 to create a system that will use image analysis and real-time 3D modelling of the production process
Containment

Inivos unveils ProXcide Mini: the future of small-chamber bio-decontamination

From biosafety cabinets to isolators, the ProXcide Mini offers reliable bioburden reduction in spaces others can’t reach
Subscribe now